Development of an Immune-Related Prognostic Signature in Breast Cancer

Abstract

We developed a 12-gene prognostic signature, providing novel insights into the identification of breast cancer with a high risk of death and assessment of the possibility of immunotherapy incorporation in personalized breast cancer management.